GenomOncology and Congenica Announce Collaborative Development of Novel Precision Oncology Solution
CAMBRIDGE, England–(BUSINESS WIRE)–#lifechanginganswers–Congenica, a UK-based digital health company that enables the rapid analysis and interpretation of genomic data, has selected the GenomOncology Precision Oncology Platform for the development of a novel ground-breaking CE-IVD Precision Oncology Solution. Driven by the increasing adoption of cancer genomics and the growing need to individualize therapeutic recommendations, Congenica is developing … [Read more…]